Inventor · disambiguated record
Neil I. Goldstein
Also filed as: GOLDSTEIN NEIL · GOLDSTEIN NEIL I
14 granted patents·20 pending applications·1,156 citations·filing 1984–2023
95Inventor score
Top patents by PatentIndex Score
34 records- 0197US4699880AMethod of producing monoclonal anti-idiotype antibodyIMMUNOMEDICS INC·Filed 1984·Granted Oct 13, 1987·247 cites·6 claims
- 0295US7060808B1Humanized anti-EGF receptor monoclonal antibodyIMCLONE SYSTEMS INC·Filed 1996·Granted Jun 13, 2006·167 cites·24 claims
- 0395US6811779B2Methods for reducing tumor growth with VEGF receptor antibody combined with radiation and chemotherapyIMCLONE SYSTEMS INC·Filed 2001·Granted Nov 2, 2004·99 cites·27 claims
- 0494US6365157B2Monoclonal antibodies specific to VEGF receptors and uses thereofIMCLONE SYSTEMS INC·Filed 1999·Granted Apr 2, 2002·133 cites·17 claims
- 0592US5840301AMethods of use of chimerized, humanized, and single chain antibodies specific to VEGF receptorsIMCLONE SYSTEMS INC·Filed 1994·Granted Nov 24, 1998·110 cites·40 claims
- 0691US5955311AMonoclonal antibodies specific to VEGF receptors and uses thereofIMCLONE SYSTEMS INC·Filed 1998·Granted Sep 21, 1999·83 cites·8 claims
- 0791US5874542ASingle chain antibodies specific to VEGF receptorsIMCLONE SYSTEMS INC·Filed 1997·Granted Feb 23, 1999·79 cites·12 claims
- 0890US6875741B2Insulin and IGF-1 receptor agonists and antagonistsFiled 2001·Granted Apr 5, 2005·69 cites·30 claims
- 0989US6448077B1Chimeric and humanized monoclonal antibodies specific to VEGF receptorsIMCLONE SYSTEMS INC·Filed 1997·Granted Sep 10, 2002·53 cites·38 claims
- 1088US7173005B2Insulin and IGF-1 receptor agonists and antagonistsNOVO NORDISK AS·Filed 2002·Granted Feb 6, 2007·25 cites·5 claims
- 1182US5861499ANucleic acid molecules encoding the variable or hypervariable region of a monoclonal antibody that binds to an extracellular domainIMCLONE SYSTEMS INC·Filed 1996·Granted Jan 19, 1999·53 cites·8 claims
- 1268US5547670ARecombinant hybrid porin epitopesIMCLONE SYSTEMS INC·Filed 1993·Granted Aug 20, 1996·26 cites·4 claims
- 1366US2009053807A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 1466US2007116707A1Antibody and antibody fragments for inhibiting the growth of tumorsGOLDSTEIN NEIL I·Filed 2006·Application pending·0 cites
- 1565US2009099339A1Antibody and antibody fragments for inhibiting the growth of tumorsIMCLONE SYSTEMS INC·Filed 2008·Application pending·0 cites
- 1665US2009192072A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2008·Application pending·0 cites
- 1765US2005004066A1Monoclonal antibodies specific to VEGF receptors and uses thereofFiled 2004·Application pending·0 cites
- 1861US2009022716A1Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonistIMCLONE SYSTEMS INC·Filed 2007·Application pending·0 cites
- 1961US2007265189A1Insulin and igf-1 receptor agonists and antagonistsNOVO NORDISK AS·Filed 2007·Application pending·0 cites
- 2060US2004006212A1Antibody and antibody fragments for inhibiting the growth of tumorsFiled 2003·Application pending·0 cites
- 2159US2009022714A1Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonistIMCLONE SYSTEMS INC·Filed 2006·Application pending·0 cites
- 2258US2002192213A1Monoclonal antibodies specific to VEGF receptors and uses thereofFiled 2002·Application pending·0 cites
- 2357US2025082769A1Cellular uptake peptide-therapeutic payload compositions and methods of useNIGHTHAWK BIOSCIENCES INC·Filed 2023·Application pending·0 cites
- 2457US2003108545A1Combination methods of inhibiting tumor growth with a vascular endothelial growth factor receptor antagonistFiled 2002·Application pending·0 cites
- 2557US2003236190A1Isulin and IGF-1 receptor agonists and antagonistsFiled 2002·Application pending·0 cites
- 2656US7056679B2Target specific screening and its use for identifying target bindersANTYRA INC·Filed 2002·Granted Jun 6, 2006·5 cites·8 claims
- 2754US2024368278A1Generation and characterization of novel tim-4 binding agentsHEAT BIOLOGICS INC·Filed 2022·Application pending·0 cites
- 2853US2011124556A1Insulin and IGF-1 Receptor Agonists and AntagonistsNOVO NORDISK AS·Filed 2010·Application pending·0 cites
- 2951US2007004634A1Insulin and IGF-1 receptor agonists and antagonistsANTYRA INC·Filed 2006·Application pending·0 cites
- 3048US2003224001A1Antibody and antibody fragments for inhibiting the growth of tumorsFiled 2003·Application pending·0 cites
- 3145US2003219821A1Methods for identifying oncogenes and tumor-associated proteinsFiled 2002·Application pending·0 cites
- 3241US2003054348A1Methods of identifying the activity of gene productsFiled 2001·Application pending·0 cites
- 3339US6413717B1Methods for indentifying anti-cancer agentsCORIXA CORP·Filed 1998·Granted Jul 2, 2002·7 cites·28 claims
- 3429US2016318995A1Randomized Humanized Antibody Libraries Engineered with Sequence and Insert DiversityHELIO GENETICS INC·Filed 2016·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →